EHS
EHS

Survival in patients with neuroendocrine tumors of the colon, rectum and small intestine


    • Yao J.C.
    • Hassan M.
    • Phan A.
    • et al.

    One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

    J Clin Oncol. 2008; 26: 3063-3072

    • Garcia-Carbonero R.
    • Capdevila J.
    • Crespo-Herrero G.
    • et al.

    Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).

    Ann Oncol. 2010; 21: 1794-1803

    • Lawrence B.
    • Gustafsson B.I.
    • Chan A.
    • Svejda B.
    • Kidd M.
    • Modlin I.M.

    The epidemiology of gastroenteropancreatic neuroendocrine tumors.

    Endocrinol Metabol Clin. 2011; 40: 1-18

    • Shen C.
    • Yin Y.
    • Chen H.
    • et al.

    Neuroendocrine tumors of colon and rectum: validation of clinical and prognostic values of the World Health Organization 2010 grading classifications and European Neuroendocrine Tumor Society staging systems.

    Oncotarget. 2017; 822123

    • Dasari A.
    • Shen C.
    • Halperin D.
    • et al.

    Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States.

    JAMA Oncol. 2017; 3: 1335-1342

  • Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences?.

    Curr Oncol Rep. 2021; 23: 1-7

  • Neuroendocrine Tumors of the Gastrointestinal Tract. Atlas of Intestinal Pathology.

    Springer,
    2019: 93-109

    • Merchant S.H.
    • VanderJagt T.
    • Lathrop S.
    • Amin M.B.

    Sporadic duodenal bulb gastrin-cell tumors: association with Helicobacter pylori gastritis and long-term use of proton pump inhibitors.

    Am J Surg Pathol. 2006; 30: 1581-1587

    • Garbrecht N.
    • Anlauf M.
    • Schmitt A.
    • et al.

    Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.

    Endocr Relat Cancer. 2008; 15: 229-241

    • Concors S.J.
    • Sinnamon A.J.
    • Folkert I.W.
    • et al.

    Predictors of metastases in rectal neuroendocrine tumors: results of a national cohort study.

    Dis Colon Rectum. 2018; 61: 1372-1379

    • de Mestier L.
    • Lorenzo D.
    • Fine C.
    • et al.

    Endoscopic, transanal, laparoscopic, and transabdominal management of rectal neuroendocrine tumors.

    Best Pract Res Clin Endocrinol Metabol. 2019; 33101293

    • Modlin I.M.
    • Lye K.D.
    • Kidd M.

    A 5‐decade analysis of 13,715 carcinoid tumors.

    Cancer: Interdiscipl Int J Am Cancer Soc. 2003; 97: 934-959

    • Tsikitis V.L.
    • Wertheim B.C.
    • Guerrero M.A.

    Trends of incidence and survival of gastrointestinal neuroendocrine tumors in the United States: a seer analysis.

    J Cancer. 2012; 3: 292

  • Rectal carcinoids.

    Curr Opin Gastroenterol. 2006; 22: 529-535

  • Rectal carcinoids are on the rise: early detection by screening endoscopy.

    Endoscopy. 2009; 41 (): 162-165

    • Taghavi S.
    • Jayarajan S.N.
    • Powers B.D.
    • Davey A.
    • Willis A.I.

    Examining rectal carcinoids in the era of screening colonoscopy: a surveillance, epidemiology, and end results analysis.

    Dis Colon Rectum. 2013; 56: 952-959

    • Van Gompel J.J.
    • Sippel R.S.
    • Warner T.F.
    • Chen H.

    Gastrointestinal carcinoid tumors: factors that predict outcome.

    World J Surg. 2004; 28: 387-392

    • Onaitis M.W.
    • Kirshbom P.M.
    • Hayward T.Z.
    • et al.

    Gastrointestinal carcinoids: characterization by site of origin and hormone production.

    Ann Surg. 2000; 232: 549

    • Rothenstein J.
    • Cleary S.P.
    • Pond G.R.
    • et al.

    Neuroendocrine tumors of the gastrointestinal tract: a decade of experience at the Princess Margaret Hospital.

    Am J Clin Oncol. 2008; 31: 64-70

    • Maggard M.A.
    • O’Connell J.B.
    • Ko C.Y.

    Updated population-based review of carcinoid tumors.

    Ann Surg. 2004; 240: 117

    • Chagpar R.
    • Chiang Y.-J.
    • Xing Y.
    • et al.

    Neuroendocrine tumors of the colon and rectum: prognostic relevance and comparative performance of current staging systems.

    Ann Surg Oncol. 2013; 20: 1170-1178

    • Yu Y.-J.
    • Li Y.-W.
    • Shi Y.
    • Zhang Z.
    • Zheng M.-Y.
    • Zhang S.-W.

    Clinical and pathological characteristics and prognosis of 132 cases of rectal neuroendocrine tumors.

    World J Gastrointest Oncol. 2020; 12: 893

    • Sohn B.
    • Kwon Y.
    • Ryoo S.-B.
    • et al.

    Predictive factors for lymph node metastasis and prognostic factors for survival in rectal neuroendocrine tumors.

    J Gastrointest Surg. 2017; 21: 2066-2074

    • Bosman F.T.
    • Carneiro F.
    • Hruban R.H.
    • Theise N.D.

    WHO Classification of Tumours of the Digestive System.

    World Health Organization,
    2010

    • Klimstra D.
    • Klöppel G.
    • La Rosa S.
    • Rindi G.

    Classification of Neuroendocrine Neoplasms of the Digestive System. WHO Classification of Tumours.

    fifth ed. 2019: 16-19 ()

  • Gastroenteropancreatic neuroendocrine tumors.

    CA A Cancer J Clin. 2018; 68: 471-487

    • Strosberg J.
    • El-Haddad G.
    • Wolin E.
    • et al.

    Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors.

    N Engl J Med. 2017; 376: 125-135

    • Yao J.C.
    • Fazio N.
    • Singh S.
    • et al.

    Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.

    Lancet. 2016; 387: 968-977

  • Genetics and epigenetics of gastroenteropancreatic neuroendocrine neoplasms.

    Endocr Rev. 2019; 40: 506-536

    • Strosberg J.R.
    • Weber J.M.
    • Feldman M.
    • Coppola D.
    • Meredith K.
    • Kvols L.K.

    Prognostic validity of the American Joint Committee on Cancer staging classification for midgut neuroendocrine tumors.

    J Clin Oncol. 2013; 31: 420-425

    • National Cancer Institute

    Surveillance, epidemiology, and end results (SEER).

    • Nagtegaal I.D.
    • Odze R.D.
    • Klimstra D.
    • et al.

    The 2019 WHO classification of tumours of the digestive system.

    Histopathology. 2020; 76: 182

    • Wu Z.
    • Wang Z.
    • Zheng Z.
    • Bi J.
    • Wang X.
    • Feng Q.

    Risk factors for lymph node metastasis and survival outcomes in colorectal neuroendocrine tumors.

    Cancer Manag Res. 2020; 12: 7151

    • Zhao B.
    • Hollandsworth H.M.
    • Lopez N.E.
    • et al.

    Outcomes for a large cohort of patients with rectal neuroendocrine tumors: an analysis of the national cancer database.

    J Gastrointest Surg. 2021; 25: 484-491

    • Wang Y.
    • Zhang Y.
    • Lin H.
    • et al.

    Risk factors for lymph node metastasis in rectal neuroendocrine tumors: a recursive partitioning analysis based on multicenter data.

    J Surg Oncol. 2021;

    • Wei G.
    • Feng X.
    • Wang W.
    • et al.

    Analysis of risk factors of lymph node metastasis in rectal neuroendocrine neoplasms using multicenter data.

    Future Oncol. 2018; 14: 1817-1823

  • Surgical management of rectal carcinoids: trends and outcomes from the Surveillance, Epidemiology, and End Results database (1988 to 2012).

    Am J Surg. 2016; 211: 877-885

    • Shields C.J.
    • Tiret E.
    • Winter D.C.
    • Group I.R.C.S.

    Carcinoid tumors of the rectum: a multi-institutional international collaboration.

    Ann Surg. 2010; 252: 750-755

    • Al Natour R.H.
    • Saund M.S.
    • Sanchez V.M.
    • et al.

    Tumor size and depth predict rate of lymph node metastasis in colon carcinoids and can be used to select patients for endoscopic resection.

    J Gastrointest Surg. 2012; 16: 595-602

    • Zhou X.
    • Xie H.
    • Xie L.
    • Li J.
    • Fu W.

    Factors associated with lymph node metastasis in radically resected rectal carcinoids: a systematic review and meta-analysis.

    J Gastrointest Surg. 2013; 17: 1689-1697

    • Dasari A.
    • Mehta K.
    • Byers L.A.
    • Sorbye H.
    • Yao J.C.

    Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: a SEER database analysis of 162,983 cases.

    Cancer. 2018; 124: 807-815

    • Shia J.
    • Tang L.H.
    • Weiser M.R.
    • et al.

    Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?.

    Am J Surg Pathol. 2008; 32: 719-731

    • Basturk O.
    • Tang L.
    • Hruban R.H.
    • et al.

    Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases.

    Am J Surg Pathol. 2014; 38: 437

    • Felderspiel B.
    • Burke A.
    • Sobin L.
    • Shekitka K.
    • Helwig E.

    Rectal and colonic carcinoids.

    Cancer. 1990; 65: 135-140

    • Frizziero M.
    • Chakrabarty B.
    • Nagy B.
    • et al.

    Mixed neuroendocrine non-neuroendocrine neoplasms: a systematic review of a controversial and underestimated diagnosis.

    J Clin Med. 2020; 9: 273



  • Source link

    EHS
    Back to top button